Review

Published on 30 Aug 2021

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs

in Pharmacogenetics and Pharmacogenomics

Laura Molenaar-Kuijsten
Dorieke E. M. Van Balen
Jos H. Beijnen
Neeltje Steeghs
Alwin D. R. Huitema

Frontiers in Pharmacology

doi 10.3389/fphar.2021.670862

14,560 views
20 citations

Original Research

Published on 27 Aug 2021

CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population

in Pharmacogenetics and Pharmacogenomics

Xinyi Huang
Chao Li
Chaopeng Li
Zhenyu Li
Xiaohui Li
Jianwei Liao
Tai Rao
Lulu Chen
Lichen Gao
Dongsheng Ouyang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.730461

5,932 views
7 citations

Original Research

Published on 26 Aug 2021

CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting

in Pharmacogenetics and Pharmacogenomics

Kuntheavy Ing Lorenzini
Jules Desmeules
Victoria Rollason
Stéphane Bertin
Marie Besson
Youssef Daali
Caroline F. Samer

Frontiers in Pharmacology

doi 10.3389/fphar.2021.730637

5,651 views
15 citations

Review

Published on 25 Aug 2021

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

in Pharmacogenetics and Pharmacogenomics

Alireza Tafazoli
Henk-Jan Guchelaar
Wojciech Miltyk
Adam J. Kretowski
Jesse J. Swen

Frontiers in Pharmacology

doi 10.3389/fphar.2021.693453

15,139 views
35 citations

Original Research

Published on 18 Aug 2021

Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors

in Pharmacogenetics and Pharmacogenomics

Temidayo Adeluwa
Brett A. McGregor
Kai Guo
Junguk Hur

Frontiers in Pharmacology

doi 10.3389/fphar.2021.648805

6,100 views
11 citations

Original Research

Published on 13 Aug 2021

Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

in Pharmacogenetics and Pharmacogenomics

Albert Martínez-Pinteño
Patricia Gassó
Llucia Prohens
Alex G. Segura
Mara Parellada
Jerónimo Saiz-Ruiz
Manuel J. Cuesta
Miguel Bernardo
Amalia Lafuente
Sergi Mas

Frontiers in Pharmacology

doi 10.3389/fphar.2021.729474

5,195 views
3 citations

Original Research

Published on 26 Jul 2021

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B15:02 and HLA-A31:01 Across Diverse Ancestral Backgrounds

in Pharmacogenetics and Pharmacogenomics

Amanda Buchner
Xiuying Hu
Katherine J. Aitchison

Frontiers in Pharmacology

doi 10.3389/fphar.2021.713178

5,293 views
3 citations

Brief Research Report

Published on 23 Jul 2021

CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region

in Pharmacogenetics and Pharmacogenomics

Paula Ferreira Salles
Daiana Souza Perce-da-Silva
Atila Duque Rossi
Luisa Riehl Raposo
Aina Danaisa Ramirez Ramirez
Otílio Machado Pereira Bastos
Lilian Rose Pratt-Riccio
Gustavo Capatti Cassiano
Andrea Regina Souza Baptista
Cynthia Chester Cardoso

Frontiers in Pharmacology

doi 10.3389/fphar.2021.542342

2,614 views
3 citations

Original Research

Published on 16 Jul 2021

Mutational Characteristics of Causative Genes in Chinese Hereditary Spherocytosis Patients: a Report on Fourteen Cases and a Review of the Literature

in Pharmacogenetics and Pharmacogenomics

Dong Wang
Li Song
Li Shen
Kaihui Zhang
Yuqiang Lv
Min Gao
Jian Ma
Ya Wan
Zhongtao Gai
Yi Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2021.644352

3,642 views
20 citations

Review

Published on 14 Jul 2021

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

in Pharmacogenetics and Pharmacogenomics

Paula Soria-Chacartegui
Gonzalo Villapalos-García
Pablo Zubiaur
Francisco Abad-Santos
Dora Koller

Frontiers in Pharmacology

doi 10.3389/fphar.2021.711940

17,034 views
37 citations

Original Research

Published on 12 Jul 2021

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China

in Pharmacogenetics and Pharmacogenomics

Chengxian Guo
Biwen Hu
Chengjun Guo
Xiangguang Meng
Yun Kuang
Longjian Huang
Danling Wang
Kangwei Xu
Yanlin Zhao
Guoping Yang

Frontiers in Pharmacology

doi 10.3389/fphar.2021.682020

5,312 views
20 citations

Original Research

Published on 09 Jul 2021

The Association Between STX1B Polymorphisms and Treatment Response in Patients With Epilepsy

in Pharmacogenetics and Pharmacogenomics

Shitao Wang
Liang Zhou
Chenglu He
Dan Wang
Xuemei Cai
Yanying Yu
Liling Chen
Di Lu
Ligong Bian
Sunbing Du

Frontiers in Pharmacology

doi 10.3389/fphar.2021.701575

2,825 views
5 citations

Brief Research Report

Published on 05 Jul 2021

CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients

in Pharmacogenetics and Pharmacogenomics

Yilei Yang
Xin Huang
Yinping Shi
Rui Yang
Haiyan Shi
Xinmei Yang
Guoxiang Hao
Yi Zheng
Jianning Wang
Lequn Su

Frontiers in Pharmacology

doi 10.3389/fphar.2021.692922

4,496 views
6 citations

Review

Published on 28 Jun 2021

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia

in Pharmacogenetics and Pharmacogenomics

Meike Kaehler
Ingolf Cascorbi

Frontiers in Pharmacology

doi 10.3389/fphar.2021.696960

5,112 views
26 citations

Original Research

Published on 28 Jun 2021

Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice

in Pharmacogenetics and Pharmacogenomics

Fadhli Adesta
Caroline Mahendra
Kathleen Irena Junusmin
Arya Melissa Selva Rajah
Sharon Goh
Levana Sani
Alexandre Chan
Astrid Irwanto

Frontiers in Pharmacology

doi 10.3389/fphar.2021.684907

3,648 views
6 citations

Mini Review

Published on 21 Jun 2021

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity

in Pharmacogenetics and Pharmacogenomics

L. McEvoy
D. F. Carr
M. Pirmohamed

Frontiers in Pharmacology

doi 10.3389/fphar.2021.684162

23,557 views
46 citations

Navigation group

Articles

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs

CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population

CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors

Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B15:02 and HLA-A31:01 Across Diverse Ancestral Backgrounds

CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region

Mutational Characteristics of Causative Genes in Chinese Hereditary Spherocytosis Patients: a Report on Fourteen Cases and a Review of the Literature

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China

The Association Between STX1B Polymorphisms and Treatment Response in Patients With Epilepsy

CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia

Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity

Navigation group

Articles

A Review of CYP3A Drug-Drug Interaction Studies: Practical Guidelines for Patients Using Targeted Oral Anticancer Drugs

CYP2C19 Genotyping May Provide a Better Treatment Strategy when Administering Escitalopram in Chinese Population

CYP450 Genotype—Phenotype Concordance Using the Geneva Micrococktail in a Clinical Setting

Applying Next-Generation Sequencing Platforms for Pharmacogenomic Testing in Clinical Practice

Predicting Drug-Induced Liver Injury Using Machine Learning on a Diverse Set of Predictors

Identification of EP300 as a Key Gene Involved in Antipsychotic-Induced Metabolic Dysregulation Based on Integrative Bioinformatics Analysis of Multi-Tissue Gene Expression Data

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B*15:02 and HLA-A*31:01 Across Diverse Ancestral Backgrounds

CYP2D6 Allele Frequency in Five Malaria Vivax Endemic Areas From Brazilian Amazon Region

Mutational Characteristics of Causative Genes in Chinese Hereditary Spherocytosis Patients: a Report on Fourteen Cases and a Review of the Literature

Genetic Polymorphisms Associated With the Pharmacokinetics, Pharmacodynamics and Adverse Effects of Olanzapine, Aripiprazole and Risperidone

A Survey of Pharmacogenomics Testing Among Physicians, Pharmacists, and Researchers From China

The Association Between STX1B Polymorphisms and Treatment Response in Patients With Epilepsy

CYP3A5 Genotype-Dependent Drug-Drug Interaction Between Tacrolimus and Nifedipine in Chinese Renal Transplant Patients

Pharmacogenomics of Impaired Tyrosine Kinase Inhibitor Response: Lessons Learned From Chronic Myelogenous Leukemia

Pharmacogenomics Implementation Training Improves Self-Efficacy and Competency to Drive Adoption in Clinical Practice

Pharmacogenomics of NSAID-Induced Upper Gastrointestinal Toxicity

Validation of Single Nucleotide Variant Assays for Human Leukocyte Antigen Haplotypes HLA-B15:02 and HLA-A31:01 Across Diverse Ancestral Backgrounds